|
|
|
|
Despite accomplishments and improvements, cancer remains too common disease in the U.S.
Although there have been achievements in the battle against cancer, including a decrease in the rate of death and new diagnoses, cancer remains one of the leading causes of death in the U.S., with a need for continued improvement in the areas of...
|
|
|
Progress has been made in war on cancer, but still many challenges
Although there have been achievements in the battle against cancer, including a decrease in the rate of death and new diagnoses, cancer remains one of the leading causes of death in the U.S., with a need for continued improvement in the areas of...
|
|
|
Progress has been made in war on cancer, but still many challenges
Although there have been achievements in the battle against cancer, including a decrease in the rate of death and new diagnoses, cancer remains one of the leading causes of death in the U.S., with a need for continued improvement in the areas of...
|
|
|
NCCN Guidelines translated into Japanese
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) have been further recognized as the global standard in oncology with the announcement that select NCCN Guidelines are being translated into Japanese.The Translational Research Informatics...
|
|
|
Science wins key battles, but could cancer win the war?
Despite huge advances in prevention and treatment, cancer is poised to become the leading cause of death worldwide as people refuse to ditch bad habits and the population ages, experts said this week.In the United States, medical advances and education...
|
|
|
Science wins key battles but could cancer win the war?
by Karin Zeitvogel WASHINGTON - Despite huge advances in prevention and treatment, cancer is poised to become the leading cause of death worldwide as people refuse to ditch bad habits and the population ages, experts said Tuesday.In the United States,...
|
|
|
Science wins key battles but could cancer win the war?
WASHINGTON (AFP) - Despite huge advances in prevention and treatment, cancer is poised to become the leading cause of death worldwide as people refuse to ditch bad habits and the population ages, experts said Tuesday.In the United States, medical...
|
|
|
Powerful Radiation Therapy May Help Inoperable Lung Cancer Patients
All about: Patients with an early stage but inoperable lung cancer may be helped by an intensive radiation therapy treatment.Researchers from the University of Texas Southwestern Medical Center in Dallas TX suggest that aiming powerful beams of...
|
|
|
ABRAXANE Meets Primary Endpoint in Phase 3 Trial for Advanced Non-Small Cell Lung Cancer
The Phase 3 trial completed enrollment of 1,052 patients in July 2009 at 102 sites globally and was led by principal investigator Mark Socinski, M.D., at the University of North Carolina Lineberger Comprehensive Cancer Center.It is one of the largest...
|
|
|
ABRAXANE Meets Primary Endpoint in Phase 3 Trial for Advanced Non-Small Cell Lung Cancer
ABRAXANE, Carboplatin Combination Demonstrated Superiority to Taxol, Carboplatin in 1st Line Non-Small Cell Lung Cancer Abraxis BioScience, Inc.(NASDAQ:ABII) today announced that its randomized registrational Phase 3 clinical trial comparing...
|
|
|
Lung cancer gene tests not ready
Their review of studies aiming to show a gene signature for lung tumors found serious problems in the design and analysis of the studies.Researchers need some clear guidelines to follow in what is becoming a booming industry of using genes to predict...
|
|
|
Non-Small Cell Lung Cancer Therapy: University of Occupational and Environmental Health describes research in non-small cell lung cancer therapy
Today's Medical & Research News University of Occupational and Environmental Health describes research in therapy March 17th, 2010 Printer-Friendly Version City:Kitakyushu Country:Japan Adenocarcinoma Carcinoid Tumor Environmental Health Histology...
|
|
|
Science wins key battles but could cancer win the war? (AFP)
WASHINGTON (AFP) Despite huge advances in prevention and treatment, cancer is poised to become the leading cause of death worldwide as people refuse to ditch bad habits and the population ages, experts said Tuesday.In the United States, medical...
|
|
|
Saint Thomas uses technology to detect lung cancer faster It's called the endobronchial ultrasound transbronch
It's called the endobronchial ultrasound transbronchial needle aspiration system, and started using it just weeks ago to speed up lung cancer diagnosis and possibly save more lives.The new technology can do in one hour, sometimes even in 10...
|
|
|
New Radiation Therapy Shows Promise in Lung Cancer
Aiming powerful beams of radiation precisely at tumors helped control their growth and helped people with early stage but inoperable lung cancer live longer, U.S.researchers said on Tuesday. Aiming powerful beams of radiation precisely at...
|
|
|
SBRT improves survival in patients with inoperable non-small cell lung cancer
Highly-focused stereotactic body radiation therapy (SBRT) can eliminate the targeted tumor while avoiding treatment-related illness and may ultimately improve survival for patients with inoperable non-small cell lung cancer, according to early...
|
|
|
Reports say cancer cost needs to be reined in
AMA journal finds burden to system NEW YORK - The rising cost of cancer research and care, which helped reduce death rates by 16 percent over 40 years, is straining the U.S.health system and needs to be restrained, commentators said in a special...
|
|
|
Shutting Out Soft Tissue Cancers in the Cold
Interventional Radiologists Pioneer Potential Treatment for Cancer That Has Metastasized to Soft Tissues (Such as Ovarian Cancer) and Bones; Seen as Option for Those Who Are Not Candidates for Surgery TAMPA, Fla.(Logo: http://www.newscom.com/cgi...
|
|
|
Gene Expression Based Prognostic Signatures in Lung Cancer Not Ready for Clinical Use
A review of published articles on gene expression based prognostic signatures in lung cancer revealed little evidence that any of the signatures are ready for clinical use, according to researchers at NCI.Serious problems in the design and...
|
|
|
Abraxis BioScience (ABII) Tops Taxol in Cancer Study
Abraxis BioScience Inc.(ABII), a California based global biotechnology company focusing on cancer treatments, announced today that its chemotherapeutic compound ABRAXANE has demonstrated a significant improvement in overall response rate in the...
|
|
|
New Radiation Therapy for Lung Cancer Cure
Modalities - Radiology U.S.researchers said that aiming powerful beams of radiation precisely at tumors helped control their growth and helped people with early stage but inoperable lung cancer live longer. The researchers said intensive...
|
|
|
New Radiation Therapy Extends Lives of Lung Cancer Patients
Aiming powerful beams of radiation precisely at tumors helped control their growth and helped people with early stage but inoperable lung cancer live longer, U.S.researchers said on Tuesday. They said intensive radiation therapy done in one to...
|
|
|
Sysmex Starts Joint Research with National Cancer Center Hospital
Sysmex Corporation has started research jointly with the National Cancer Center Hospital to verify clinical usefulness of a technology developed by Sysmex for detecting living tumor cells suspended in blood (CTC detection technology).The prognosis for...
|
|
|
US slashes cancer death rate
US doctors and scientists have made huge strides in the fight against cancer in the past four decades, slashing the death rate by nearly 16%, a report published on Tuesday showed.But cancer remained the second leading cause of death in the United...
|
|
|
UPDATE 1-Abraxis cancer drug meets late-stage trial goal
DRUG IMPROVED RESPONSE RATE IN LUNG CANCER PATIENTS * Co plans to file for approval in lung cancer in 2011 * Shares up 6 pct in premarket trade March 17 (Reuters) - Abraxis BioScience Inc said a late-stage study testing its cancer...
|
